Cardiff Lexington Corporation (CDIX)
OTCMKTS · Delayed Price · Currency is USD
5.00
0.00 (0.00%)
At close: Jul 30, 2025
United States Steel Revenue
Cardiff Lexington had revenue of $2.92M in the quarter ending March 31, 2025, with 25.56% growth. This brings the company's revenue in the last twelve months to $8.86M, down -22.72% year-over-year. In the year 2024, Cardiff Lexington had annual revenue of $8.27M, down -30.23%.
Revenue (ttm)
8.86M
Revenue Growth
-22.72%
P/S Ratio
11.10
Revenue / Employee
553.97K
Employees
17
Market Cap
98.40M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.27M | -3.58M | -30.23% |
Dec 31, 2023 | 11.85M | 1.16M | 10.85% |
Dec 31, 2022 | 10.69M | 814.14K | 8.24% |
Dec 31, 2021 | 9.88M | 6.43M | 186.10% |
Dec 31, 2020 | 3.45M | -254.30K | -6.86% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Cardiff Lexington News
- 3 days ago - Cardiff Lexington Announces Second Quarter 2025 Financial Results - Accesswire
- 2 months ago - Cardiff Lexington Announces Uplisting to OTCQB Venture Market - Accesswire
- 2 months ago - Cardiff Lexington Announces First Quarter 2025 Financial Results - Accesswire
- 4 months ago - Cardiff Lexington Announces Fourth Quarter and Full Year 2024 Financial Results - Accesswire
- 9 months ago - Cardiff Lexington Announces Third Quarter 2024 Financial Results - Accesswire
- 1 year ago - Cardiff Lexington Announces Second Quarter 2024 Financial Results - Accesswire
- 1 year ago - Cardiff Lexington Opens 12th Nova Ortho and Spine Location in Orlando, Florida - Accesswire
- 1 year ago - Cardiff Lexington Announces Elimination of Convertible Debt - Accesswire